The Food and Drug Administration (FDA) approved a new drug to treat a disorder causing the growth of non-cancerous tumors on ...

University of Queensland research using natural killer cells may lead to the first new treatment for a devastating childhood ...

Nathan Congdon, MD, highlights a recent study showing how virtual mentor-mentee relationships through Orbis' free ...

IFB-088 (icerguastat) was safe and significantly slowed disease progression in certain people with ALS in a Phase 2 clinical trial.

Compared with adults aged 65 and older, those aged 18 to 64 are more affected by long COVID neurologic symptoms.

To Know in detail about the Neuroblastoma market outlook, drug uptake, treatment scenario, and epidemiology trends, Click here: Neuroblastoma Market Forecast Some of the key facts of the Neuroblastoma ...

The study used gold-standard autopsy confirmation to show that a blood test for Alzheimer's disease accurately detected ...

In this video, Annick Desjardins, MD, professor of neurosurgery, professor of neurology and member of the Duke Cancer Institute, explains how clinicians may treat patients with gliomas of different ...

A team of researchers from the Keck School of Medicine of USC has unlocked the details of a cellular pathway that triggers ...